This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Drexel University, Inovio Pharmaceuticals, Inc., University of Pennsylvania. Active years: 2016.
Company Filing History:
1 out of 668 
1 out of 93 
1 out of 2,655 
Years Active: 2016
Title: Scott Baliban: Innovator in Vaccine Development
Introduction
Scott Baliban is a notable inventor based in Southampton, NJ (US). He has made significant contributions to the field of vaccine development, particularly in relation to Clostridium difficile, a bacterium that can cause severe gastrointestinal issues.
Latest Patents
Scott Baliban holds a patent for a Clostridium difficile DNA vaccine. This invention relates to compositions and methods for treating associated disease (CDAD) through the administration to a subject in need thereof at least one nucleic acid encoding at least a portion of at least one of toxin A and toxin B. His innovative approach aims to provide a more effective treatment for those affected by this challenging condition.
Career Highlights
Throughout his career, Scott has worked with several prominent organizations. He has been associated with the Philadelphia Health and Education Corporation and Inovio Pharmaceuticals, Inc. These experiences have allowed him to contribute to groundbreaking research and development in the medical field.
Collaborations
Scott has collaborated with notable professionals in his field, including Michele Kutzler and David B. Weiner. These partnerships have further enhanced his work and the impact of his inventions.
Conclusion
Scott Baliban's contributions to vaccine development, particularly through his patent on a Clostridium difficile DNA vaccine, highlight his innovative spirit and dedication to improving public health. His work continues to inspire advancements in medical research and treatment options.